Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
about
Autoimmune Myopathies: Where Do We Stand?Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathyA Rare Case of Necrotizing Myopathy and Fibrinous and Organizing Pneumonia with Anti-EJ Antisynthetase Syndrome and SSA Antibodies.Roles of mast cells in the pathogenesis of inflammatory myopathySecreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis.Complement membrane attack complex is related with immune-mediated necrotizing myopathy.Magnetic resonance imaging at 7T reveals common events in age-related sarcopenia and in the homeostatic response to muscle sterile injury.Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.An overview of polymyositis and dermatomyositis.Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.Multi-parametric MRI characterization of inflammation in murine skeletal muscle.Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathyThe tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.Brief report: antisynthetase syndrome-associated myocarditisA case report of autoimmune necrotizing myositis presenting as dysphagia and neck swelling.Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.Paraneoplastic neurological syndromes: severe neurological symptoms resulting from relatively benign or occult tumours-two case reports.Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.Serum interleukin-6 expression level and its clinical significance in patients with dermatomyositisSignal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Laboratory evaluation in rheumatic diseases.Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features.T cells in myositis.Frequency and spectrum of myopathies in patients with psoriasis.Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.Corticosteroids in Myositis and Scleroderma.Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin.Autoimmune Myopathies.Personalized medicine in rheumatology: the paradigm of serum autoantibodies.7-Tesla magnetic resonance imaging precisely and noninvasively reflects inflammation and remodeling of the skeletal muscle in a mouse model of antisynthetase syndrome.Statin-associated polymyositis following omeprazole treatment.Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy.Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.Potential role of autophagy in T‑cell survival in polymyositis and dermatomyositis.Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.Identification of novel autoantigens by a triangulation approach.
P2860
Q26744554-E08EF1C1-D794-4811-A66A-B07BAB027C5AQ30596300-B07E073D-845D-434B-9424-54F8C4F15B85Q33620295-197B58AE-52C7-457D-9C7D-CFF140C76497Q33765803-68E5E6D1-DBDE-4EAA-9054-FCF21A74D8D2Q33888471-0AF45294-1856-49FB-934A-FF819F8A1875Q34029161-B83E1647-5DE7-4624-A44E-6ABF1D781DF8Q34648977-0D837C78-B8FD-47C6-BCB1-0D007FE69040Q34661961-6C0FC4B3-B45F-4382-8D09-F980864BAA17Q34667765-4B7DB293-A2F3-4855-ACEE-7523DADE48A8Q35095086-7C13B613-99C2-47F5-B5CC-4B933115F03CQ35159099-A8E842D8-A2A5-40A8-AFF2-B746E5534328Q35284449-464BFF28-F3F1-4B29-A12F-840C76589A9DQ35450066-FF77C03A-53EB-4746-B6BA-9AED33908E38Q35618761-11641E32-B4CC-4ACD-90E0-E2B2E5BC70DDQ36020670-7C5D3C23-C26E-4D3A-A9A3-7388FFCD4058Q36434543-49BBCD0A-A25C-47C7-AE3B-B0D97574E54CQ36664408-C984CBA7-17FA-44A1-B7D9-962BF21BC9DBQ36801659-3469A51E-1DD8-4F97-8171-B072D2497884Q36947409-EEB057FA-4755-422E-A5CD-FAD53A62DD93Q37040711-D5F5FA83-F06F-4B6E-8F41-1C365822EC3AQ37180624-F75CD183-C640-4F6A-85A8-823658089991Q37345669-2BE0A1DF-803B-4A19-B70C-2E04982D8DA1Q37674765-30D6F2DE-B518-4CE4-B083-E67C0C5849C6Q37721695-984E3877-7319-481F-9568-E0FDF1BCDD37Q37726608-2F181743-3351-4162-8BB0-882E05211E95Q38044467-54C33168-22D7-4532-89CD-ECF6C1083527Q38070033-78D374F9-674D-4614-BB81-5BB4C0FA207FQ38137819-774A22AF-9FD2-404E-B731-F232917A47C6Q38554195-B491E11B-217B-4E72-9298-89D90E0F2728Q38649505-56CAFA32-5395-449F-95B5-B740B20886FCQ38879035-1A2D76F2-3699-4A69-BD36-FE4691E91290Q39030495-72853505-1358-4EDD-B19F-5EC489177ECFQ39432157-E103A13B-486A-4EA1-8F41-FB7FB6AD99CDQ39764555-7B8A30CD-2161-4707-9236-D73112C53ADAQ41825872-A8509236-E3E1-4EE3-BEC6-C3CBBF8FCF3EQ42014200-D363BB91-1DB1-4B49-ADDF-667EC274C08EQ42233198-1D6FECCC-4A77-452B-8E98-C0568125ED81Q42347137-8E7DB9EB-4F8D-4F52-82E6-06A7C51E6AF6Q42365039-B7EE7E6B-DD0A-49B8-B4DF-8C545897DBBCQ42702963-7F3D7CBB-B63C-4561-BD6C-EAA40FB3A7A1
P2860
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
@en
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
@nl
type
label
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
@en
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
@nl
prefLabel
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
@en
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
@nl
P2860
P356
P1476
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
@en
P2093
Andrew L Mammen
P2860
P2888
P304
P356
10.1038/NRNEUROL.2011.63
P407
P577
2011-06-08T00:00:00Z